Cleared Abbreviated

K041088 - TRIFUSION

K041088 is the FDA 510(k) clearance for TRIFUSION by C.R. Bard, Inc.. It is a Class 2 General Hospital device (product code LJS) cleared through the Abbreviated 510(k) pathway after a 189-day FDA review.

K041088 · C.R. Bard, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2004
Decision
189d
Days
Class 2
Risk

K041088 is an FDA 510(k) clearance for the TRIFUSION, MODEL 0609190/0659350. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on November 1, 2004 after a review of 189 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K041088 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2004
Decision Date November 01, 2004
Days to Decision 189 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 129d · This submission: 189d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 180
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K041088.
POWERHOHN AND POWERLINE CATHETERS
K050185 · C.R. Bard, Inc. · May 2005
6 FR POLY PER-Q-CATH TRIPLE LUMEN PICC
K043502 · C.R. Bard, Inc. · Jan 2005
BD ONECATH PERIPHERALLY INSERTED CENTRAL CATHETER
K042491 · Becton, Dickinson & CO · Nov 2004
PREMICATH, 1261.205
K041468 · Vygon Corp. · Sep 2004
PICC
K042126 · Arrow Intl., Inc. · Aug 2004
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K041420 · AngioDynamics, Inc. · Jul 2004